James Stallworth to Cost-Benefit Analysis
This is a "connection" page, showing publications James Stallworth has written about Cost-Benefit Analysis.
Connection Strength
0.634
-
We Can Teach How to Bend the Cost Curve: Lessons in Pediatric High-Value Health Care. Pediatrics. 2017 03; 139(3).
Score: 0.481
-
Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. Am J Hematol. 2010 Oct; 85(10):795-7.
Score: 0.077
-
Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease. Ann Hematol. 2011 Feb; 90(2):145-50.
Score: 0.077